Abstract
The practice of outpatient medicine is demanding, encompasses a wide scope of practice, and leaves little time for internists to stay up to date with the current literature. This article reviews 5 studies published in 2022 and 2023 that have the potential to change the practice of outpatient medicine. Topics covered include chronic kidney disease, secondary cardiovascular disease, kidney stones, obesity, and lipid management.
Author supplied keywords
- Empagliflozin slowed the progression of chronic kidney disease in patients with chronic kidney disease
- Ezetimibe
- Tirzepatide was effective for weight loss in patients who were obese or overweight with weight-related complications
- added to lower-intensity statin therapy
- the benefit was most pronounced in patients with significant albuminuria. A Mediterranean diet was superior to a low-fat diet for secondary prevention of major cardiovascular events. Hydrochlorothiazide did not decrease symptomatic or radiologic recurrence of calcium-containing kidney stones
- was noninferior to high-intensity statin therapy with respect to major adverse cardiovascular events
Cite
CITATION STYLE
Alexander, J. T., Singh, S. K., Shah, S. D., Lambert, B., & Smith, J. P. (2024). 2023 Update in ambulatory general internal medicine. Cleveland Clinic Journal of Medicine. Cleveland Clinic Educational Foundation. https://doi.org/10.3949/ccjm.91a.23056
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
